Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2021-07-26 5:21 pm Purchase | 13G | EYEPOINT PHARMACEUTICALS, INC. EYPT | SUVRETTA CAPITAL MANAGEMENT LLC | 1,595,164 5.6% | 1,595,164 (New Position) | View |
| 2021-02-12 4:06 pm Purchase | 13G | EYEPOINT PHARMACEUTICALS, INC. EYPT | ADAGE CAPITAL PARTNERS GP L.L.C. | 1,500,000 5.23% | 1,500,000 (New Position) | View |
| 2021-02-01 2:18 pm Purchase | 13G | EYEPOINT PHARMACEUTICALS, INC. EYPT | FRANKLIN RESOURCES INC BEN | 1,413,947 7.8% | 1,413,947 (New Position) | View |
| 2021-01-21 6:21 pm Purchase | 13D | EYEPOINT PHARMACEUTICALS, INC. EYPT | Ocumension Therapeutics | 3,010,722 16.6% | 3,010,722 (New Position) | View |
| 2020-11-10 10:47 am Purchase | 13G | EYEPOINT PHARMACEUTICALS, INC. EYPT | FRANKLIN RESOURCES INC BEN | 14,137,500 10.6% | 14,137,500 (New Position) | View |